Cortés-Cortés Eduardo, Salazar Franco Raúl, Ebromares Martínez Isidro, García-Mellado De Cortés Olivia, Naranjo-Rodríguez Elia Brosla, López-Rubalcava Carolina
Instituto de Química, Universidad Nacional Autónoma de México, México.
Proc West Pharmacol Soc. 2007;50:87-92.
Eight of a series of twelve new 2-[(o-; and p-substituted)aminophenyl]-3H-5-[(o-; and p-substituted)phenyl]-7-chloro-1,4-benzodiazepinines (VI, 1-12; Fig. 1) and two of eleven new 1-alkyl-3H-5-[(o-; and p-substituted)phenyl]-7-chloro-1,4-benzodiazepin-2-one (IV, 1-12; Fig. 2) were tested for their pharmacological and/or biological activity as anxiolytics.
在一系列十二个新的2-[(邻位和对位取代)氨基苯基]-3H-5-[(邻位和对位取代)苯基]-7-氯-1,4-苯并二氮杂䓬(VI,1 - 12;图1)中,测试了八个化合物;在一系列十一个新的1-烷基-3H-5-[(邻位和对位取代)苯基]-7-氯-1,4-苯并二氮杂䓬-2-酮(IV,1 - 12;图2)中,测试了两个化合物,以评估它们作为抗焦虑药的药理和/或生物学活性。